Opthea

About:

Opthea Limited is a public Australian biotechnology company .

Website: http://www.opthea.com/

Twitter/X: Opthea1

Top Investors: The Carlyle Group, Abingworth

Description:

Opthea Limited (formerly Circadian Technologies) is a public Australian biotechnology company developing novel biologic therapies for the treatment of eye diseases. Opthea's lead compound, OPT-302, blocks two members of the vascular endothelial growth factor family, namely VEGF-C and VEGF-D, which cause blood vessels to grow and leak. Aberrant blood vessel growth and vascular leakage are hallmarks of several eye diseases including wet age-related macular degeneration (wet AMD).